Pharma Times

AUGUST 4, 2021

Sativex is a complex botanical formulation that contains the principal cannabinoids THC and CBD

162

162

pharmaphorum

AUGUST 6, 2021

There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is currently “middling” it is on the rise, according to a report from IQVIA. The pandemic contributed to another 90,000 apps being introduced in 2020 – an average of 250 per day – and this coupled with rising number and functionality of wearable devices “provides evidence of digital health’s acc

Diabetes 145

Diabetes 145

Outsourcing Pharma

AUGUST 5, 2021

A leader from the clinical research tech specialist explains how the use of AI is increasing in the field and outlines the many ways it could SOMETHING.

145

145

NY Times

AUGUST 3, 2021

The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.

Vaccines 145

Vaccines Hospitals Immunity Immunization 145

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

AUGUST 2, 2021

Saphnelo is the first type I interferon receptor agonist to receive regulatory approval

138

138

pharmaphorum

AUGUST 4, 2021

Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord. It’s a debilitating condition that affects 1 per 8,000 to 10,000 people worldwide , impacting their ability to walk, eat, and breathe. SMA Type 1 represents an estimated 50% of all cases, for which life expectancy is less than 18 months without treatment. .

145

145

Drug Patent Watch

AUGUST 6, 2021

This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Bulgaria? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Times

AUGUST 5, 2021

Agreement will support use of the 'best evidence-based healthcare' in the NHS

131

131

pharmaphorum

AUGUST 4, 2021

Fresenius has launched a virtual reality based training programme for people undergoing home dialysis in Germany, its home market, ahead of a rollout in other countries later this year. The VR system – called stay•safe MyTraining VR – is designed for use in patients undergoing peritoneal dialysis, which uses the peritoneum in a person’s abdomen as the membrane through which fluid and dissolved substances are exchanged with the blood.

Diabetes 111

Diabetes 111

Outsourcing Pharma

AUGUST 3, 2021

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharma in Brief

AUGUST 3, 2021

The Federal Court of Appeal has quashed an excessive-price decision of the Patented Medicine Prices Review Board ( PMPRB ) in a proceeding concerning the drug SOLIRIS. The matter has been remitted to the PMPRB for redetermination. Procedural background. The PMPRB issued a decision in 2017 finding that Alexion Pharmaceuticals Inc. sold SOLIRIS (eculizumab) at an excessive price in Canada and ordering Alexion to remit excess revenues earned between 2009 and 2017.

87

87

Pharma Times

AUGUST 4, 2021

Less than one in 20 children had symptoms for more than four weeks

131

131

pharmaphorum

AUGUST 4, 2021

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial. In the phase 2b/3 ALLEGRO trial, JAK inhibitor ritlecitinib hit its primary objective of improving the area of scalp covered by hair in people with this autoimmune form of hair loss, giving Pfizer a positive readout in the first of two trials that will form the basis of regulatory filings for the drug.

Labelling 107

Labelling Immunity Immunization 107

Outsourcing Pharma

AUGUST 2, 2021

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.

119

119

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for RIOMET Riomet is a drug marketed by Ranbaxy and Sun Pharm and is included in two NDAs. It is available from one supplier. There are…. The post New patent expiration for Ranbaxy drug RIOMET appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 4, 2021

Phase III trials did not demonstrate sufficient clinical benefit.

131

131

pharmaphorum

AUGUST 6, 2021

Patient enrollment is a common issue across many therapeutic areas in clinical research. Psychiatric disorders in particular represent a trial area with significantly high drop-out rates and poor patient recruitment. The reasons behind this problem, however, are rarely studied or understood. Despite this, new strategies devised over the last five years are beginning to reverse the trend, and both reduce stigma and increase awareness to funnel new patients into these important trials. .

Hospitals 105

Hospitals Communication 105

Outsourcing Pharma

AUGUST 4, 2021

An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 6, 2021

UK Competition and Markets Authority provisionally finds drug companies broke competition law

123

123

pharmaphorum

AUGUST 3, 2021

The FDA has relaxed a clinical hold on clinical trials of Novartis’ intrathecal formulation of spinal muscular atrophy (SMA) gene therapy Zolgensma, allowing a new phase 3 trial to get underway. Zolgensma (onasemnogene abeparvovec) is already approved as an intravenous treatment in babies and very young children for the rare muscle-wasting disease, but the new OAV-101 IT version is designed to unlock use of the drug in older SMA patients.

105

105

Outsourcing Pharma

AUGUST 2, 2021

Arcturus Therapeutics and its Vietnam partner Vinbiocare will take ARCT-154, a next-generation Arcturus vaccine targeting SARS-CoV-2 variants of concern, into a Phase 1/2/3 trial. The companies will also establish a vaccine manufacturing centre in Vietnam.

Vaccines 105

Vaccines 105

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-two…. The post New patent for Teva Pharm drug ARMONAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 6, 2021

Planned Phase II study to combine the BET inhibitor with momelotinib

123

123

pharmaphorum

AUGUST 2, 2021

Ipsen’s new chief executive David Loew pledged to ramp up spending on the company’s pipeline when he took the helm last year, and a flurry of licensing deals in the last few weeks shows that push is starting to gather momentum. The French company – which focusing on cancer, neuroscience and rare diseases – has just snapped up two programmes from US biotech Exicure that span the latter two areas, targeted at rare neurodegenerative disorders Huntington’s disease and Angelman synd

105

105

Outsourcing Pharma

AUGUST 3, 2021

Adoption of single-use technologies has grown exponentially over the last decade: but what will drive the tech forward in the coming years?

98

98

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…. The post New patent for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 6, 2021

Acquisition strengthens Bayer’s drug discovery capabilities

123

123

pharmaphorum

AUGUST 4, 2021

The need for automated metadata management software has never been greater. The number of global clinical trials being run is increasing every year. And, they are becoming increasingly complex to manage. There’s a vast amount of data that needs to be collected and analyzed. There are more regulations in place than ever before and industry standards are constantly being updated.

Communication 98

Communication Documentation 98

Outsourcing Pharma

AUGUST 2, 2021

The drug, intended for adult patients with moderate-to-severe systemic lupus erythematosus, is the only new therapy approved for SLE in more than a decade.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management